Sign in
4

Changes in Ownership

Vir Biotechnology, Inc. Filed Acc 0001628280-26-012395

EVP & Chief Financial Officer sold 1,634 shares at $9.53 ($15,576)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
O'Byrne Jason EVP & Chief Financial Officer 2026-02-24 Sale 10b5-1 −1,634 $9.53 $15,576 162,615 D: show line 1 in the form
Open-market sales · 1,634 sh · avg $9.53 · $15,576
Loading xslF345X05/wk-form4_1772142937.xml…